The Motley Fool
16 Nov 2025, 11:01 UTC · 44w ago
Verdict
Headline takes no side. We score DAVA −0.90 across three claims — strongly bearish.
−0.90strongly bearish
More negative than 91% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Endava lowered its full-year sales guidance to a range of 735 million to 752 million pounds, implying a 3.5% decline at the midpoint.
So whatLowering forward-looking revenue guidance typically triggers significant valuation contractions as it signals weakening demand.
More negative than 99% of claims this week
Endava reported a year-over-year sales decline of 8.7% for its first quarter of fiscal 2026, missing both previous guidance and analyst expectations.
So whatA substantial miss in top-line growth for a tech services firm suggests operational struggles or a loss of market share.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
More negative than 98% of claims this week
Recent financial results have raised questions among investors regarding the efficacy and trajectory of Endava's artificial intelligence strategies.
So whatFailure to monetize AI trends is a major risk factor for current tech valuations and long-term growth narratives.
More negative than 91% of claims this week
Which stocks this story touches
More negative than 91% of ticker scores this week
The company experienced a dramatic stock price collapse following substantial sales and earnings misses and lowered full-year guidance.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
−57.5%
Price agrees with the score
$2.79 vs $6.56 close before publication (Nov 14) · not market-adjusted
DAVA chart →